Future of the pharmacogenomics of calcineurin inhibitors in renal transplant patients

被引：6
|
作者：
Zhu, Huaijun [1 ]
Ge, Weihong [1 ]
机构：
[1] Nanjing Univ, Affiliated Nanjing Drum Tower Hosp, Sch Med, Dept Pharm, Nanjing 210008, Jiangsu, Peoples R China
来源：
PHARMACOGENOMICS | 2011年 / 12卷 / 11期
关键词：
calcineurin inhibitor; epigenetics; orphan nuclear receptor; pharmacogenomics; renal transplantation; REGULATED GENE-EXPRESSION; RECIPIENTS; THERAPY; PHARMACOKINETICS; PHARMACODYNAMICS; PERSPECTIVES; CELLS; CYP3A;
D O I：
10.2217/PGS.11.129
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1505 / 1508
页数：4
相关论文
共 50 条
  • [1] Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients
    Santoro, Ana
    Felipe, Claudia R.
    Tedesco-Silva, Helio
    Medina-Pestana, Jose O.
    Struchiner, Claudio J.
    Ojopi, Elida B.
    Suarez-Kurtz, Guilherme
    PHARMACOGENOMICS, 2011, 12 (09) : 1293 - 1303
  • [2] Calcineurin inhibitors in pediatric renal transplant recipients
    Filler G.
    Pediatric Drugs, 2007, 9 (3) : 165 - 174
  • [3] Relationship between pharmacokinetics and pharmacodynamics of calcineurin inhibitors in renal transplant patients
    Albring, Antje
    Wendt, Laura
    Harz, Nino
    Engler, Harald
    Wilde, Benjamin
    Kribben, Andreas
    Lindemann, Monika
    Schedlowski, Manfred
    Witzke, Oliver
    CLINICAL TRANSPLANTATION, 2015, 29 (04) : 294 - 300
  • [4] The effect of calcineurin inhibitors on endothelial and platelet function in renal transplant patients
    Sahin, G.
    Akay, O. M.
    Bal, C.
    Yalcin, A. U.
    Gulbas, Z.
    CLINICAL NEPHROLOGY, 2011, 76 (03) : 218 - 225
  • [5] Proteinuria following switch from calcineurin inhibitors to sirolimus in renal transplant patients
    Colak, Turan
    Gorur, Sarp K.
    Karakayali, Hamdi
    Haberal, Mehmet
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 273 - 274
  • [6] Sirolimus experience in liver transplant patients with renal insufficiency due to calcineurin inhibitors
    Meyer, C
    Lazzari, L
    Bonaccorsi, E
    Dervaux, T
    Ellero, B
    Woehl, ML
    Audet, M
    Jaeck, D
    Wolf, P
    JOURNAL OF HEPATOLOGY, 2004, 40 : 50 - 50
  • [7] INTENSIVE PHARMACOVIGILANCE PROGRAM OF CALCINEURIN INHIBITORS IN PEDIATRIC RENAL AND HEPATIC TRANSPLANT PATIENTS
    Riva, N.
    Caceres Guido, P.
    Rousseau, M.
    Ibanez, J.
    Cambaceres, C.
    Mato, G.
    Monteverde, M.
    Schaiquevich, P.
    PEDIATRIC RESEARCH, 2013, 73 (03) : 380 - 380
  • [8] Lipid parameters, doses and blood levels of calcineurin inhibitors in renal transplant patients
    Ciftci H.S.
    Ayna T.K.
    Calıskan Y.K.
    Turkmen A.
    Gurtekin M.
    Indian Journal of Clinical Biochemistry, 2013, 28 (2) : 164 - 168
  • [9] Elimination of calcineurin inhibitors in paediatric renal transplant recipients
    Prytula, A. A.
    Dorresteijn, E.
    van Rooij, R.
    Keijzer-Veen, M. G.
    Cransberg, K.
    PEDIATRIC NEPHROLOGY, 2011, 26 (09) : 1609 - 1609
  • [10] Drug interaction between calcineurin inhibitors and calcium channel blockers in renal transplant patients
    Ben Sassi, M.
    Gaies, E.
    Charfi, R.
    Jebali, N.
    El Jebari, H.
    Lakhal, M.
    Klouz, A.
    Salouage, I.
    Trabesli, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 73 - 73
12345